Panagora Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Panagora Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-796	Closed	-$42K	–	3117
2020 Q3	$42K	Buy	+796	New	+$49.1K	﹤0.01%	2062
2017 Q4	–	Sell	-9,532	Closed	-$443K	–	2389
2017 Q3	$443K	Sell	9,532 -9,154	-49%	-$438K	﹤0.01%	1394
2017 Q2	$925K	Buy	18,686 +7,425	+66%	+$389K	﹤0.01%	1153
2017 Q1	$617K	Buy	11,261 +3,879	+53%	+$205K	﹤0.01%	1316
2016 Q4	$411K	Buy	+7,382	New	+$355K	﹤0.01%	1515

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Panagora Asset Management's BSTC Position: Q4 2020 in Review

Panagora Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 796 shares — an estimated $42K sold.

Panagora Asset Management first reported a position in BSTC in Q4 2016 and held it in 5 quarters. The position peaked at $925K in Q2 2017. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Panagora Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Panagora Asset Management sold 796 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $42K.
Panagora Asset Management first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and held it in 5 quarters.
Panagora Asset Management's BioSpecifics Technologies Corp. position peaked at $925K in Q2 2017.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.